View details of this raise on Seedstage

Mesa, AZ

Advancing commercial launch of a non-invasive AI-powered health device to make disease prevention accessible and scalable.

• Non-invasive technology: Measures multiple biomarkers in seconds with no needles or consumables.
• AI-powered insights: Uses light and machine learning for clinical-grade accuracy in health monitoring.
• Strong clinical validation: 3,700+ patients tested across four studies with additional trials underway.
• Cost-effective prevention: Reduces monitoring costs by up to 95% for individuals and healthcare systems.
• Commercial readiness: Preparing for 2026 launch with manufacturing and regulatory plans in motion.

Viit Health is raising funds to bring its non-invasive, AI-powered health monitoring device to market, aiming to make preventive care more accessible and affordable worldwide. The device uses light-based technologies combined with artificial intelligence to deliver fast, accurate measurements of key health biomarkers such as blood glucose, blood pressure, oxygen saturation, and heart rate, all without needles or consumables. Designed for personal, clinical, and public health use, this solution drastically reduces the cost and time of vital health assessments. The funds will support commercial deployment, clinical trials, regulatory submissions, and manufacturing scale-up as Viit Health prepares for market entry.

With validation from over 3,700 patients across four clinical trials and partnerships with major hospitals, Viit Health has demonstrated the ability to close the gap between wellness tracking and clinical-grade accuracy. The company is targeting a large global market driven by rising chronic disease prevalence and growing demand for personalized, preventive care. Its business model includes a dual-path subscription approach for individuals and providers, making it both scalable and sustainable. By eliminating the need for multiple devices and reducing the pain, cost, and complexity of traditional health monitoring, Viit Health aims to change how early detection and disease prevention are delivered. This raise will fund final product development, regulatory approvals, and early commercial traction ahead of a full-scale launch expected by mid-2026.

Company Info

Viit Health provides a non-invasive device that uses light and AI to monitor health biomarkers for early disease detection and prevention.

Viit Health has developed a compact, non-invasive health monitoring device that uses light-based technologies and AI to measure key biomarkers such as blood glucose, blood pressure, heart rate, and oxygen saturation in under 30 seconds. Unlike traditional methods that require multiple devices, finger pricks, or clinic visits, the Viit device consolidates monitoring into a single portable solution, significantly reducing both cost and time. The technology has been validated through four clinical trials involving more than 3,700 patients and is supported by a strong network of institutional and research partners across the U.S. and Mexico.

The company’s platform leverages multiple optical techniques, including Near Infrared Transmittance Spectroscopy and Photoplethysmography, to deliver personalized insights aimed at early disease detection and prevention. Viit Health targets a broad range of non-communicable diseases such as hypertension and diabetes, which collectively account for the majority of global mortality. With a dual business model—subscriptions for both clinical settings and individual users—the company aims to make proactive health monitoring accessible and scalable. Commercial rollout is planned for 2026, with confirmed early clients and a projected expansion to 15,000 units across Latin America and North America by 2028.